FindTrial
Sign In

The expression and clinical significance of S1PR 5 in peripheral blood of patients with sepsis

The expression and clinical significance of S1PR 5 in peripheral blood of patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074052
Enrollment
Unknown
Registered
2023-07-28
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

experimental group:none
control group:none

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Sepsis meets the criteria of 3 Diagnostic criteria: Clear or suspected infection with a Sequential Organ Failure (SOFA) score of = 2 points

Exclusion criteria

Exclusion criteria: (1) Treatment time<48 hours; (2) Age<18 years old; ? Pregnancy period.

Design outcomes

Primary

MeasureTime frame
S1PR5(sphingosine-1-phosphate receptor 5);S1P(sphingosine-1-phosphate);PKD(protein kinase B);—

Secondary

MeasureTime frame
IL-6(interleukin-6);IL-10(interleukin-10);—

Countries

China

Contacts

Public ContactLiu xiaofeng

Emergency Department of the First Affiliated Hospital of Gannan Medical University

liuxiaofeng1@gmu.cn+86 137 6639 4083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026